GLAND PHARMA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,728 INR | -0.59% |
|
-2.00% | -10.19% |
| Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
| Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
Chart calendar Gland Pharma Limited
d2dba3785e5d9477c1a3.c5x7CJXA_ZdeBOyCTayoXjII-pmOL_IR7Lx_aaIHIT0.FPYuXMeCmqUoW5qzf5SRb2hRtO65RYh71dtGLfRQQ1Mj9DV61q622hMyoQ~064a99daa32d71ab6acb0edcae9f4be7
Upcoming events on Gland Pharma Limited
Past events on Gland Pharma Limited
| 2024-03-25 | Investor Meeting - Ashmore Group |
| 2024-03-20 | Investor Meeting - DE Shaw (Singapore) |
| 2024-03-19 | Investor Meeting - Tantallon Capital Advisors |
| 2024-03-18 | Investor Meeting - CitiBank |
| 2024-03-13 | Investor Meeting - Emerge Capital |
| 2024-03-12 | Investor Meeting |
| 2024-03-10 | Citi India Investor Conference |
| 2024-03-07 | Investor Meeting - Capital World Investors |
| 2024-03-06 | Investor Meeting - GIC Private Limited |
| 2024-02-20 | Kotak Chasing Growth Investor Conference |
| 2024-02-15 | IIFL Enterprising India Global Investors Conference |
| 2024-02-14 08:00 am | Q3 2024 Earnings Call |
| 2024-02-14 05:49 am | Q3 2024 Earnings Release |
| 2023-12-06 | Investor Meeting - Jennison Associates |
| 2023-12-04 | Investor Meeting - Boyu Capital |
| 2023-11-23 | Investor Meeting - 360 One Asset Management |
| 2023-11-21 | Investor Meeting - J.P. Morgan |
| 2023-11-15 | Investor Meeting - Klay Capital |
| 2023-11-14 | Investor Meeting - Premji Invest |
| 2023-11-08 | Investor Meeting - HDFC Mutual Fund |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 26 332 | 34 629 34 195 1.27% | 44 007 43 949 0.13% | 36 246 39 119 -7.34% | 56 490 |
|
EBITDA Million INR | Released Forecast Spread | 0,00 | 13 022 12 859 1.27% | 15 102 15 654 -3.53% | 10 248 11 978 -14.45% | 13 492 |
|
EBIT Million INR | Released Forecast Spread | 0,00 | 12 034 11 802 1.97% | 13 999 14 511 -3.53% | 8 780 10 773 -18.49% | 10 198 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 0,00 | 13 348 12 962 2.98% | 16 186 16 792 -3.61% | 10 546 13 421 -21.42% | 11 692 |
|
Net income Million INR | Released Forecast Spread | 0,00 | 9 970 9 702 2.76% | 12 117 12 552 -3.47% | 7 810 9 968 -21.65% | 8 480 |
|
EPS INR | Released Forecast Spread | 0,00 | 63,0 59,9 5.13% | 73,6 76,8 -4.06% | 47,4 61,2 -22.54% | 51,7 |
| Announcement Date | 10/07/20 | 17/05/21 | 19/05/22 | 18/05/23 | - |
Quarterly results
| Fiscal Period | März | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 8 877 8 608 3.13% | 11 539 9 944 16.04% | 10 805 10 623 1.71% | 10 633 10 617 0.15% | 11 030 10 596 4.1% | 8 569 11 144 -23.11% | 10 444 10 223 2.16% | 9 383 11 062 -15.18% | 7 850 9 549 -17.79% | 12 087 12 232 -1.18% | 13 439 | 14 508 | 15 710 | 15 977 |
|
EBITDA Million INR | Released Forecast Spread | 3 277 3 045 7.61% | 4 363 3 777 15.5% | 3 766 3 913 -3.76% | 3 489 3 658 -4.61% | 3 484 3 853 -9.6% | 2 699 3 476 -22.35% | 2 969 3 307 -10.24% | 2 896 3 350 -13.55% | 1 684 2 939 -42.7% | 2 982 2 760 8.06% | 3 128 | 3 600 | 3 708 | |
|
EBIT Million INR | Released Forecast Spread | 3 028 3 129 -3.24% | 4 110 3 687 11.47% | 3 505 4 110 -14.72% | 3 211 3 750 -14.37% | 3 173 3 117 1.79% | 2 350 3 268 -28.09% | 2 602 2 940 -11.5% | 2 520 2 793 -9.8% | 1 309 2 537 -48.4% | 2 286 2 348 -2.61% | 2 299 | 2 769 | 2 734 | 3 116 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 489 3 122 11.77% | 4 718 3 965 19.02% | 4 007 4 257 -5.88% | 3 656 4 070 -10.18% | 3 805 3 905 -2.55% | 3 085 3 922 -21.34% | 3 241 3 687 -12.11% | 3 109 3 613 -13.96% | 1 112 3 147 -64.68% | 2 613 2 338 11.75% | 2 828 | 3 354 | 3 302 | |
|
Net income Million INR | Released Forecast Spread | 2 604 2 346 10.99% | 3 507 2 964 18.32% | 3 021 3 145 -3.94% | 2 730 2 952 -7.49% | 2 859 2 953 -3.18% | 2 292 2 933 -21.88% | 2 412 2 656 -9.18% | 2 319 2 684 -13.58% | 787 2 353 -66.57% | 1 941 1 769 9.72% | 2 161 | 2 332 | 2 337 | |
|
EPS INR | Released Forecast Spread | 21,4 19,3 10.73% | 18,4 20,5 -10.17% | 16,6 18,7 -11% | 17,4 17,9 -3.02% | 13,9 18,0 -22.45% | 14,7 18,1 -19.06% | 14,1 16,8 -16.36% | 4,78 15,1 -68.34% | 11,8 12,4 -5% | 12,7 | 13,6 | 14,2 | ||
| Announcement Date | 17/05/21 | 21/07/21 | 22/10/21 | 21/01/22 | 19/05/22 | 20/07/22 | 26/10/22 | 23/01/23 | 18/05/23 | 07/08/23 | - | - | - | - |
More events
Past sector events for Gland Pharma Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLAND Stock
- Calendar Gland Pharma Limited
